325 related articles for article (PubMed ID: 24792154)
1. TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity.
Mussolino C; Alzubi J; Fine EJ; Morbitzer R; Cradick TJ; Lahaye T; Bao G; Cathomen T
Nucleic Acids Res; 2014 Jun; 42(10):6762-73. PubMed ID: 24792154
[TBL] [Abstract][Full Text] [Related]
2. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.
Mussolino C; Morbitzer R; Lütge F; Dannemann N; Lahaye T; Cathomen T
Nucleic Acids Res; 2011 Nov; 39(21):9283-93. PubMed ID: 21813459
[TBL] [Abstract][Full Text] [Related]
3. Origins of Programmable Nucleases for Genome Engineering.
Chandrasegaran S; Carroll D
J Mol Biol; 2016 Feb; 428(5 Pt B):963-89. PubMed ID: 26506267
[TBL] [Abstract][Full Text] [Related]
4. Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases.
Cai Y; Bak RO; Mikkelsen JG
Elife; 2014 Apr; 3():e01911. PubMed ID: 24843011
[TBL] [Abstract][Full Text] [Related]
5. TALEN-Mediated Knockout of CCR5 Confers Protection Against Infection of Human Immunodeficiency Virus.
Shi B; Li J; Shi X; Jia W; Wen Y; Hu X; Zhuang F; Xi J; Zhang L
J Acquir Immune Defic Syndr; 2017 Feb; 74(2):229-241. PubMed ID: 27749600
[TBL] [Abstract][Full Text] [Related]
6. An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage.
Fine EJ; Cradick TJ; Zhao CL; Lin Y; Bao G
Nucleic Acids Res; 2014 Apr; 42(6):e42. PubMed ID: 24381193
[TBL] [Abstract][Full Text] [Related]
7. Creating designed zinc-finger nucleases with minimal cytotoxicity.
Ramalingam S; Kandavelou K; Rajenderan R; Chandrasegaran S
J Mol Biol; 2011 Jan; 405(3):630-41. PubMed ID: 21094162
[TBL] [Abstract][Full Text] [Related]
8. Improved somatic mutagenesis in zebrafish using transcription activator-like effector nucleases (TALENs).
Moore FE; Reyon D; Sander JD; Martinez SA; Blackburn JS; Khayter C; Ramirez CL; Joung JK; Langenau DM
PLoS One; 2012; 7(5):e37877. PubMed ID: 22655075
[TBL] [Abstract][Full Text] [Related]
9. The comparison of ZFNs, TALENs, and SpCas9 by GUIDE-seq in HPV-targeted gene therapy.
Cui Z; Liu H; Zhang H; Huang Z; Tian R; Li L; Fan W; Chen Y; Chen L; Zhang S; Das BC; Severinov K; Hitzeroth II; Debata PR; Jin Z; Liu J; Huang Z; Xie W; Xie H; Lang B; Ma J; Weng H; Tian X; Hu Z
Mol Ther Nucleic Acids; 2021 Dec; 26():1466-1478. PubMed ID: 34938601
[TBL] [Abstract][Full Text] [Related]
10. Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity.
Guilinger JP; Pattanayak V; Reyon D; Tsai SQ; Sander JD; Joung JK; Liu DR
Nat Methods; 2014 Apr; 11(4):429-35. PubMed ID: 24531420
[TBL] [Abstract][Full Text] [Related]
11. Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing.
Yan W; Smith C; Cheng L
Sci Rep; 2013; 3():2376. PubMed ID: 23921522
[TBL] [Abstract][Full Text] [Related]
12. Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering.
Liu J; Gaj T; Patterson JT; Sirk SJ; Barbas CF
PLoS One; 2014; 9(1):e85755. PubMed ID: 24465685
[TBL] [Abstract][Full Text] [Related]
13. Stable enhanced green fluorescent protein expression after differentiation and transplantation of reporter human induced pluripotent stem cells generated by AAVS1 transcription activator-like effector nucleases.
Luo Y; Liu C; Cerbini T; San H; Lin Y; Chen G; Rao MS; Zou J
Stem Cells Transl Med; 2014 Jul; 3(7):821-35. PubMed ID: 24833591
[TBL] [Abstract][Full Text] [Related]
14. Identification of off-target cleavage sites of zinc finger nucleases and TAL effector nucleases using predictive models.
Fine EJ; Cradick TJ; Bao G
Methods Mol Biol; 2014; 1114():371-83. PubMed ID: 24557916
[TBL] [Abstract][Full Text] [Related]
15. Off-target effects of engineered nucleases.
Yee JK
FEBS J; 2016 Sep; 283(17):3239-48. PubMed ID: 27208701
[TBL] [Abstract][Full Text] [Related]
16. Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design.
Shankar S; Sreekumar A; Prasad D; Das AV; Pillai MR
Cancer Cell Int; 2018; 18():169. PubMed ID: 30386178
[TBL] [Abstract][Full Text] [Related]
17. In silico abstraction of zinc finger nuclease cleavage profiles reveals an expanded landscape of off-target sites.
Sander JD; Ramirez CL; Linder SJ; Pattanayak V; Shoresh N; Ku M; Foden JA; Reyon D; Bernstein BE; Liu DR; Joung JK
Nucleic Acids Res; 2013 Oct; 41(19):e181. PubMed ID: 23945932
[TBL] [Abstract][Full Text] [Related]
18. TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells.
Dreyer AK; Hoffmann D; Lachmann N; Ackermann M; Steinemann D; Timm B; Siler U; Reichenbach J; Grez M; Moritz T; Schambach A; Cathomen T
Biomaterials; 2015 Nov; 69():191-200. PubMed ID: 26295532
[TBL] [Abstract][Full Text] [Related]
19. Inclusion of homologous DNA in nuclease-mediated gene targeting facilitates a higher incidence of bi-allelically modified cells.
Beaton BP; Kwon DN; Choi YJ; Kim JH; Samuel MS; Benne JA; Wells KD; Lee K; Kim JH; Prather RS
Xenotransplantation; 2015; 22(5):379-90. PubMed ID: 26381494
[TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells.
Holkers M; Cathomen T; Gonçalves MA
Methods; 2014 Sep; 69(2):179-87. PubMed ID: 24561826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
